Libera Bio

Nano-delivery of anti-cancer treatments to tumor cells. Only one delivering whole monoclonal antibodies to intracellular cancer targets.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Santiago de Compostela, Spain
  • Currency EUR
  • Founded March 2017
  • Employees 8
  • Incorporation Type Other
  • Website linkedin.com

Company Summary

Libera Bio is a preclinical stage biopharma company that has patented a unique set of delivery technologies, the MPN Technology, using proprietary nanocapsules to:
- actively target specific tumors and metastases (confidential ligand),
- deliver small molecules, biologics (e.g. monoclonal antibodies) or ... both,
- including to intracellular cancer targets ("undruggable"​ oncoproteins such as KRAS)

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free